Ensitrelvir (S-217622) is an orally bioavailable 3CL protease inhibitor for SARS-CoV-2, exhibiting potent antiviral activity with an IC50 of 13 nM. It is a valuable research tool for studying coronavirus replication and has demonstrated efficacy in both in vitro assays and in vivo animal models of infection.